Aviceda Therapeutics Funding: $210M Raised, Series C (2025)
Aviceda Therapeutics is a Biotech company based in Cambridge, Massachusetts. It has raised $210M in total funding. Latest round: Series C.
Aviceda Therapeutics funding overview
Aviceda Therapeutics is a Biotech company based in Cambridge, Massachusetts. Aviceda Therapeutics has raised $210M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2025. The round record for Aviceda Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Omega Funds, TCGX, SV Health Investors. 3 distinct backers are named across the disclosed rounds.
Aviceda Therapeutics at a glance
Total raised
$210M
Latest round
Series C
Latest round date
January 2025
Industry
Biotech
Headquarters
Cambridge, Massachusetts
Notable investors
Omega Funds, TCGX, SV Health Investors
Frequently asked about Aviceda Therapeutics funding
How much has Aviceda Therapeutics raised?
Aviceda Therapeutics has raised $210M in total disclosed funding across the rounds on record.
Who has invested in Aviceda Therapeutics?
Omega Funds, TCGX, SV Health Investors are named among the investors backing Aviceda Therapeutics.
What was the latest Aviceda Therapeutics funding round?
The most recent disclosed round is a Series C, announced in January 2025.
Where is Aviceda Therapeutics based?
Aviceda Therapeutics is based in Cambridge, Massachusetts.
What sector does Aviceda Therapeutics operate in?
Aviceda Therapeutics is tracked under Biotech from Cambridge, Massachusetts, with $210M in disclosed funding.
When did Aviceda Therapeutics last raise?
The last disclosed Aviceda Therapeutics round closed in January 2025 at Series C.
Every Aviceda Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Cambridge at a similar stage.
